Journal article icon

Journal article

MHC II molecules in inflammatory diseases: interplay of qualities and quantities.

Abstract:
It is generally accepted that MHC II molecules confer susceptibility to inflammatory diseases because of the different abilities they possess for binding and presenting peptides to T cells. A new study suggests that the level of MHC II gene expression is also a risk factor for such diseases. It shows that a polymorphism in the promoter of the MHC II transactivator (MHC2TA) gene (which encodes CIITA), leads to reduced MHC2TA expression, and hence reduced production of MHC II molecules. This predisposes to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1016/j.it.2005.08.011

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Biology
Role:
Author


Journal:
Trends in immunology More from this journal
Volume:
26
Issue:
11
Pages:
559-561
Publication date:
2005-11-01
DOI:
EISSN:
1471-4981
ISSN:
1471-4906


Language:
English
Keywords:
Pubs id:
pubs:18258
UUID:
uuid:92ae3241-abf2-41f5-a2d5-5da24a34eb6a
Local pid:
pubs:18258
Source identifiers:
18258
Deposit date:
2012-12-19
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP